Showing results (121-130 of 652) with videos related to
Sort By:
Pageof 66
NPJ Breast Cancer|November 7, 2022
Molecular differences between younger versus older ER-positive and HER2-negative breast cancersTao Qing, Thomas Karn, Mariya Rozenblit, et al.The Oncologist|October 19, 2013
Breast cancer multifocality and multicentricity and locoregional recurrenceSiobhan P Lynch, Xiudong Lei, Limin Hsu, et al.Cancer|November 17, 2006
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution studyAnne Uyei, Susan K Peterson, Julie Erlichman, et al.Cancer|October 26, 2006
Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 yearsJiachun Lu, Qingyi Wei, Melissa L Bondy, et al.Seminars in Oncology|March 31, 2004
Molecular therapeutics: promise and challengesElise C Kohn, Yiling Lu, Hongwei Wang, et al.Annals of Surgical Oncology|August 15, 2009
Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancerRegina M Fearmonti, Isis W Gayed, Edmund Kim, et al.Annals of Surgical Oncology|September 21, 2010
Does blue dye contribute to success of sentinel node mapping for breast cancer?Taewoo Kang, Min Yi, Kelly K Hunt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric CancerFunda Meric-Bernstam, Amber M Johnson, Ecaterina E Ileana Dumbrava, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer DrugsDiogo D G Bugano, Kenneth Hess, Denis L F Jardim, et al.European Journal of Immunology|September 19, 2019
Exposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumorsCaitlin A Creasy, Marie-Andrée Forget, Gopal Singh, et al.Pageof 66